Hyperhomocysteinemia in Parkinson’s disease – new variant of complications of ongoing therapy or specific biochemical marker of the disease?
I. V. Litvinenko, M. M. Odinak, O. S. Sologub, V. I. Mogilnaya, V. M. Schmeleva, A. A. Saharovskaya
Published in Annaly kliničeskoj i èksperimentalʹnoj nevrologii (Online) (01.02.2017)
Published in Annaly kliničeskoj i èksperimentalʹnoj nevrologii (Online) (01.02.2017)
Get full text
Journal Article
Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)
Litvinenko, I V, Odinak, M M, Mogil'naia, V I, Emelin, A Iu
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2007)
Get more information
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2007)
Journal Article